Philips India Share: Is This Unlisted Stock Worth Buying in 2026?

When investors hear the name Philips, they may immediately think of televisions, lighting products or home appliances. But Philips India has evolved significantly over the years. Today, the company has a strong presence in healthcare and personal health, making it quite different from the Philips business many consumers may remember.

For investors, however, there is one important difference: Philips India shares are not listed on Indian stock exchanges.

The company was delisted from Indian exchanges in 2004. Philips India has also stated that it currently does not have plans to list its equity shares again on Indian stock exchanges.

That makes Philips India an interesting case for investors looking at unlisted shares.

So, is Philips India share worth buying in 2026? Let's look at the company from an investor's perspective.

What Is Philips India?

Philips India Limited is a public company that has been operating in India for decades. Its current business is focused largely on healthcare, personal health and innovation-related services.

The company's major business segments include Personal Health, Health Systems and Innovation Services. In FY2024-25, Health Systems was the largest segment, generating sales of around ₹3,264 crore, followed by Innovation Services at approximately ₹2,328 crore and Personal Health at about ₹807 crore.

This healthcare-focused business gives Philips India exposure to areas such as medical technology, healthcare equipment and solutions, along with consumer-oriented personal health products.

Philips India Financial Performance

The company's recent financial performance is one of the key reasons investors are interested in Philips India shares.

For FY2024-25, Philips India reported gross income of approximately ₹6,631 crore, compared with ₹6,061 crore in FY2023-24. Profit before tax increased from around ₹327 crore to approximately ₹448 crore.

Profit after tax also improved from approximately ₹258 crore in FY2023-24 to around ₹309 crore in FY2024-25.

This represents a meaningful improvement in profitability.

The company's EBITDA also increased from approximately ₹508 crore to ₹680 crore during the same period, according to financial data compiled from its annual reports.

For an unlisted company, consistent profitability is particularly important because investors do not have the same liquidity and price discovery that they get with an actively traded listed stock.

Philips India Share Price

Unlike listed companies, Philips India does not have a live stock-exchange price.

The shares are available through the unlisted market, where prices can vary between platforms and transactions. For example, recent unlisted-market references have placed Philips India shares around the ₹1,050–₹1,150 range.

Investors should therefore treat these figures as indicative unlisted-market prices rather than NSE or BSE market prices.

The difference is important because an unlisted share may not have the same liquidity, transparency or immediate exit opportunity as a listed stock.

What Makes Philips India Interesting?

One of the biggest attractions is the company's established brand.

Philips has a long history in India, and Philips India operates in sectors where demand can be supported by India's growing healthcare and medical technology requirements.

The company's financial performance also provides an encouraging signal. Revenue and profitability both improved in FY2024-25, while retained earnings increased during the year. The company reported cash and cash equivalents of approximately ₹247 crore at March 31, 2025.

Another interesting point is that the company is not dependent entirely on consumer electronics. Its Health Systems and Innovation Services businesses form a significant part of its revenue base.

Why the Unlisted Status Matters

The biggest issue for an investor is not necessarily the business itself. It is liquidity.

Because Philips India is not listed on NSE or BSE, investors cannot simply open a trading app and sell their shares whenever they want.

The company itself has acknowledged the liquidity problem faced by minority shareholders. In a 2023 explanatory statement, Philips India noted that certain retail shareholders had difficulty monetising their holdings because the shares were no longer traded on Indian stock exchanges.

This is an important consideration for anyone thinking about buying Philips India unlisted shares.

An investor may have to wait for a suitable buyer or transaction opportunity to exit.

Does Philips India Have an IPO or Relisting Plan?

This is where investors need to be particularly careful.

There is currently no basis to assume that Philips India will soon launch an IPO or relist its shares.

The company has explicitly stated that it does not have plans for listing its equity shares on Indian stock exchanges.

Therefore, investors should not buy Philips India unlisted shares purely because they expect a near-term listing.

The investment case needs to stand on the company's underlying business, financial performance and the price at which the unlisted shares are purchased.

Philips India Share: Key Risks

Philips India may have a well-known brand and an established business, but that does not make its unlisted shares risk-free.

1. Limited Liquidity

The biggest concern is the lack of a regular stock-market trading mechanism. Exiting an investment can take time.

2. No Confirmed Relisting

Investors should not build their investment thesis around a future IPO or relisting because the company has stated that it currently has no plans to list its shares.

3. Price Discovery

Unlisted shares do not have the continuous price discovery available on NSE or BSE. Different market participants may quote different prices.

4. Business Competition

Philips India operates in competitive healthcare and personal health markets. Technology changes, competition and pricing pressure can influence future growth.

5. Valuation Matters

Even a financially strong company can become a poor investment if purchased at an excessive valuation. Investors should compare the unlisted share price with earnings, book value and the company's growth prospects before investing.

Should You Buy Philips India Share in 2026?

Philips India presents an unusual investment opportunity.

On one side, the company has an established brand, a significant healthcare business and improving financial performance. FY2024-25 showed growth in revenue, profit before tax and profit after tax.

On the other side, investors are buying an unlisted security with limited liquidity and no confirmed relisting plan.

Therefore, the question should not simply be, "Is Philips India a good company?"

The more important question is:

"Is Philips India available at a price that adequately compensates me for the risks of owning an unlisted share?"

For investors comfortable with long holding periods and limited liquidity, Philips India may be worth researching further. But investors looking for easy buying and selling, transparent market pricing or a near-term listing opportunity may find the stock less suitable.

Ultimately, Philips India can be viewed as a business-quality and valuation story rather than an IPO or quick-listing story. Anyone considering the shares should review the latest financial statements, verify the current unlisted-market price and understand the exit mechanism before investing.

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice or a recommendation to buy or sell Philips India shares. Unlisted investments can carry additional liquidity and valuation risks. Investors should conduct their own research and consult a qualified financial adviser before making an investment decision.